Fielmann Aktiengesellschaft (FIE.DE)
EUR 41.9
(2.07%)
EUR 41.9
(2.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 593.44 Million EUR | 30.6% |
| 2022 | 454.41 Million EUR | 60.36% |
| 2021 | 283.36 Million EUR | -12.0% |
| 2020 | 322 Million EUR | 33.02% |
| 2019 | 242.06 Million EUR | 276.28% |
| 2018 | -137.32 Million EUR | 19.5% |
| 2017 | -170.57 Million EUR | -51.32% |
| 2016 | -112.72 Million EUR | -19.03% |
| 2015 | -94.69 Million EUR | 24.94% |
| 2014 | -126.16 Million EUR | 6.9% |
| 2013 | -135.5 Million EUR | 51.04% |
| 2012 | -276.76 Million EUR | -131.44% |
| 2011 | -119.58 Million EUR | 10.09% |
| 2010 | -133 Million EUR | -99.55% |
| 2009 | -66.65 Million EUR | 43.12% |
| 2008 | -117.18 Million EUR | -10.01% |
| 2007 | -106.52 Million EUR | -2.38% |
| 2006 | -104.04 Million EUR | -27.09% |
| 2005 | -81.87 Million EUR | -106.23% |
| 2004 | -39.69 Million EUR | 29.84% |
| 2003 | -56.58 Million EUR | -34.62% |
| 2002 | -42.02 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 180.88 Million EUR | 121.03% |
| 2024 Q1 | 81.83 Million EUR | -84.65% |
| 2023 Q1 | 360.96 Million EUR | -20.57% |
| 2023 Q3 | 169.63 Million EUR | -52.76% |
| 2023 Q2 | 359.07 Million EUR | -0.52% |
| 2023 Q4 | 533.22 Million EUR | 214.34% |
| 2023 FY | 593.44 Million EUR | 30.6% |
| 2022 Q2 | 301.01 Million EUR | 3.95% |
| 2022 Q1 | 289.56 Million EUR | 2.19% |
| 2022 Q3 | 378.41 Million EUR | 25.71% |
| 2022 FY | 454.41 Million EUR | 60.36% |
| 2022 Q4 | 454.41 Million EUR | 20.08% |
| 2021 Q1 | 268.53 Million EUR | -16.6% |
| 2021 Q3 | 262.69 Million EUR | -0.42% |
| 2021 Q4 | 283.36 Million EUR | 7.87% |
| 2021 FY | 283.36 Million EUR | -12.0% |
| 2021 Q2 | 263.79 Million EUR | -1.77% |
| 2020 Q3 | 131.79 Million EUR | -40.81% |
| 2020 FY | 322 Million EUR | 33.02% |
| 2020 Q4 | 322 Million EUR | 144.32% |
| 2020 Q2 | 222.65 Million EUR | 7.3% |
| 2020 Q1 | 207.51 Million EUR | -14.27% |
| 2019 Q4 | 242.06 Million EUR | 15.56% |
| 2019 Q3 | 209.47 Million EUR | 29.46% |
| 2019 Q2 | 161.79 Million EUR | -30.76% |
| 2019 FY | 242.06 Million EUR | 276.28% |
| 2019 Q1 | 233.67 Million EUR | 270.16% |
| 2018 Q3 | -156.37 Million EUR | 46.69% |
| 2018 Q1 | -214.78 Million EUR | -25.92% |
| 2018 FY | -137.32 Million EUR | 19.5% |
| 2018 Q2 | -293.3 Million EUR | -36.56% |
| 2018 Q4 | -137.32 Million EUR | 12.18% |
| 2017 FY | -170.57 Million EUR | -51.32% |
| 2017 Q4 | -170.57 Million EUR | -9.17% |
| 2017 Q3 | -156.24 Million EUR | -79.7% |
| 2017 Q2 | -86.94 Million EUR | 46.06% |
| 2017 Q1 | -161.18 Million EUR | -42.99% |
| 2016 Q2 | -164.13 Million EUR | -66.89% |
| 2016 FY | -112.72 Million EUR | -19.03% |
| 2016 Q4 | -112.72 Million EUR | 27.36% |
| 2016 Q3 | -155.18 Million EUR | 5.45% |
| 2016 Q1 | -98.34 Million EUR | -3.85% |
| 2015 FY | -94.69 Million EUR | 24.94% |
| 2015 Q1 | -152.19 Million EUR | -20.64% |
| 2015 Q4 | -94.69 Million EUR | 8.27% |
| 2015 Q3 | -103.23 Million EUR | 47.1% |
| 2015 Q2 | -195.16 Million EUR | -28.23% |
| 2014 Q2 | -236.63 Million EUR | -21.15% |
| 2014 Q1 | -195.32 Million EUR | -44.14% |
| 2014 FY | -126.16 Million EUR | 6.9% |
| 2014 Q4 | -126.16 Million EUR | 32.41% |
| 2014 Q3 | -186.64 Million EUR | 21.12% |
| 2013 Q1 | -193.3 Million EUR | 30.16% |
| 2013 FY | -135.5 Million EUR | 51.04% |
| 2013 Q4 | -135.5 Million EUR | 16.86% |
| 2013 Q3 | -162.99 Million EUR | 32.41% |
| 2013 Q2 | -241.15 Million EUR | -24.75% |
| 2012 Q4 | -276.76 Million EUR | -85.21% |
| 2012 Q3 | -149.43 Million EUR | 36.15% |
| 2012 Q2 | -234.04 Million EUR | -36.48% |
| 2012 Q1 | -171.48 Million EUR | -43.4% |
| 2012 FY | -276.76 Million EUR | -131.44% |
| 2011 Q3 | -80.8 Million EUR | 19.27% |
| 2011 Q1 | -92.3 Million EUR | 27.9% |
| 2011 Q2 | -100.09 Million EUR | -8.44% |
| 2011 Q4 | -119.58 Million EUR | -47.99% |
| 2011 FY | -119.58 Million EUR | 10.09% |
| 2010 Q3 | -83.42 Million EUR | 24.85% |
| 2010 FY | -133 Million EUR | -99.55% |
| 2010 Q4 | -128.02 Million EUR | -53.46% |
| 2010 Q1 | -80.24 Million EUR | -20.4% |
| 2010 Q2 | -111.01 Million EUR | -38.33% |
| 2009 FY | -66.65 Million EUR | 43.12% |
| 2009 Q4 | -66.65 Million EUR | 0.0% |
| 2008 FY | -117.18 Million EUR | -10.01% |
| 2007 FY | -106.52 Million EUR | -2.38% |
| 2006 FY | -104.04 Million EUR | -27.09% |
| 2005 FY | -81.87 Million EUR | -106.23% |
| 2004 FY | -39.69 Million EUR | 29.84% |
| 2003 FY | -56.58 Million EUR | -34.62% |
| 2002 FY | -42.02 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 47.97 Million EUR | -1137.014% |
| Carl Zeiss Meditec AG | 145.09 Million EUR | -309.004% |
| Gerresheimer AG | 918.96 Million EUR | 35.423% |
| Sartorius Aktiengesellschaft | 4.93 Billion EUR | 87.968% |
| Sartorius Aktiengesellschaft | 4.93 Billion EUR | 87.968% |